Mevacor OTC Study Shows Cholesterol-Lowering Consistent With Rx Statins
This article was originally published in The Tan Sheet
Executive Summary
A cholesterol self-management program for OTC Mevacor was effective in deterring consumers from improperly purchasing the nonprescription version of the cholesterol-lowering drug, results from the CUSTOM actual-use study show
You may also be interested in...
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
The American Pharmacists Association's proposed "pharmacy care" model fell short of convincing FDA advisory panelists to recommend OTC status for Mevacor Daily
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
The American Pharmacists Association's proposed "pharmacy care" model fell short of convincing FDA advisory panelists to recommend OTC status for Mevacor Daily
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
The American Pharmacists Association's proposed "pharmacy care" model fell short of convincing FDA advisory panelists to recommend OTC status for Mevacor Daily